This item is authorised by the following title:
National Health Legislation Amendment (Maximum Dispensed Quantities) Instrument 2024 (PB 14 of 2024 | F2024L00236)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2024 (No. 2) (PB 15 of 2024 | F2024L00237)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2024 (No. 1) (PB 1 of 2024 | F2024L00119)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 13) (PB 128 of 2023 | F2023L01747)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 12) (PB 112 of 2023 | F2023L01575)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 11) (PB 105 of 2023 | F2023L01452)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 10) (PB 91 of 2023 | F2023L01331)
National Health Legislation Amendment (Opioid Dependence Treatment and Maximum Dispensed Quantities) Instrument 2023 (PB 57 of 2023 | F2023L00843)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 8) (PB 79 of 2023 | F2023L01147)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 9) (PB 86 of 2023 | F2023L01154)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 7) (PB 67 of 2023 | F2023L01051)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 6) (PB 54 of 2023 | F2023L00910)
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 5) (PB 43 of 2023 | F2023L00646)
